Andrew Perry
Corporate Officer/Principal at G1 THERAPEUTICS, INC.
Net worth: 256 760 $ as of 2024-06-29
Andrew Perry active positions
| Companies | Position | Start | End |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-08-01 | - |
Career history of Andrew Perry
Former positions of Andrew Perry
| Companies | Position | Start | End |
|---|---|---|---|
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - | - |
Training of Andrew Perry
| University of Glasgow | Graduate Degree |
| The University of Sheffield | Graduate Degree |
Statistics
International
| United Kingdom | 4 |
| United States | 2 |
Operational
| Graduate Degree | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Andrew Perry
- Experience
